- A. Health Biotechnology
- Areas of activity
- In vitro diagnostics
- Therapeutic areas
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Blood and lymphatic system
- Metabolic disorders / Endocrinology
Vivia Biotech pioneers the screening of thousands of drugs directly in patient´s blood samples,an innovative Systems Biology research model, really translational, which has allowed implementing for the first time in the world the Exvitech Tecnological Platform, property of Vivia Biotech.
Vivia Biotech is a worldwide pioneer in screening thousands of drugs or combinations in a patient sample through its proprietary ExviTech© technology platform.
Vivia has developed and clinically validated a Personalized Medicine Test for Hematological Cancers that identifies the best available drug combination treatment for each individual patient. The test discriminates between sensible and resistant protocol treatments for each patient, and uses gold standard diagnostic equipment (flow cytometry), adding automation and data mining capabilities.
Smart Reprofiling : by analyzing thousands of drugs on a patient's sample, we identify potentially effective drugs for a disease in the most direct way which, until now, was not possible.